A new trial finds guselkumab is highly effective and well tolerated for moderate to severe scalp psoriasis in individuals ...

Guselkumab improves scalp psoriasis and quality of life in patients with skin of color.

Psoriasis is a chronic autoimmune condition that mainly affects the skin. When you have psoriasis, your immune system sends ...

Discover a study that demonstrates the effectiveness of guselkumab in treating scalp psoriasis, offering significant symptom ...

Researchers evaluated the efficacy and safety of icotrokinra for treating plaque psoriasis affecting the scalp, genital, and/or hand/foot areas.

A new Delphi consensus led by the National Psoriasis Foundation proposes a standardized definition of on-treatment remission ...

AD and psoriasis were once thought to be opposites in terms of immune response, with AD linked to a Th2-dominant pathway and ...

For patients with psoriasis and Type 2 diabetes, the risk of developing chronic kidney disease (CKD) continued to rise ...

Low testosterone and limited sleep emerged as key, independent contributors to psoriasis risk, revealing modifiable targets ...

Involvement of problematic areas -- scalp, intertriginous sites, soles of the feet -- also figures into the assessment and has the potential to complicate use of topical therapies. If topical ...

TUESDAY, May 27, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Zoryve (roflumilast) topical foam 0.3 percent for the treatment of plaque psoriasis of the scalp and ...